Supplementary Figure S2 from Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials
crossref（2024）
摘要
Supplementary Figure S2. Changes in innate immune responses during acalabrutinib and combined ibrutinib+venetoclax by sub cohort.
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要